CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,037,646
- in 4 filings
Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-26 | Wildman Daniel George Director | Option exercise | +2,000 | 2,000 | ||
| 2025-11-26 | Wildman Daniel George Director | Option exercise · Restricted Stock Unit | −2,000 | 6,000 | ||
| 2025-11-19 | Schoenberg Mark Chief Medical Officer | Sale 10b5-1 | −10,000 | $25.00 | $250K | 139,025 |
| 2025-10-08 | Degnan Chris Chief Financial Officer | Option exercise | +4,483 | 4,483 | ||
| 2025-10-08 | Degnan Chris Chief Financial Officer | Sale | −2,203 | $16.85 | $37K | 2,280 |
| 2025-10-08 | Degnan Chris Chief Financial Officer | Option exercise · Restricted Stock Units | −4,483 | 8,967 | ||
| 2025-09-08 | Schoenberg Mark Chief Medical Officer | Sale | −871 | $19.11 | $17K | 149,025 |
| 2025-09-08 | Smith Jason Drew General Counsel | Sale | −1,520 | $19.11 | $29K | 43,305 |
| 2025-09-07 | Schoenberg Mark Chief Medical Officer | Option exercise | +1,667 | 149,896 | ||
| 2025-09-07 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −1,667 | 1,667 | ||
| 2025-09-07 | Smith Jason Drew General Counsel | Option exercise | +3,333 | 44,825 | ||
| 2025-09-07 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −3,333 | 3,334 | ||
| 2025-08-26 | Wildman Daniel George Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2025-08-26 | Wildman Daniel George Director | Grant or award · Restricted Stock Unit | +8,000 | 8,000 | ||
| 2025-08-26 | Robinson James A. Jr. Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2025-08-26 | Robinson James A. Jr. Director | Grant or award · Restricted Stock Unit | +8,000 | 8,000 | ||
| 2025-08-26 | Holden Stuart Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2025-08-26 | Holden Stuart Director | Grant or award · Restricted Stock Unit | +8,000 | 8,000 | ||
| 2025-08-26 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2025-08-26 | BUTITTA CYNTHIA M Director | Grant or award · Restricted Stock Unit | +8,000 | 8,000 |
Page 4 of 13 · 244 trades